Literature DB >> 19146640

Parkinson's disease and nursing home placement: the economic impact of the need for care.

C Vossius1, O B Nilsen, J P Larsen.   

Abstract

BACKGROUND AND
PURPOSE: To examine the relative risk (RR) for living in nursing homes for patients with Parkinson's disease (PD) compared with the general population and to ascertain society's costs related to nursing home placement for this patient group.
METHODS: We evaluated the frequency of admission to nursing homes in a cross-sectional study and during a 12-year follow-up study of 108 patients with PD and 864 controls who were matched for age and sex. The RR for living in a nursing home was calculated at baseline and during follow-up. On the basis of 2007 prices, we estimated the costs per person year of survival for patients with PD and controls.
RESULTS: The RR for living in a nursing home at baseline was 5.0 for patients with PD and 4.8 during follow-up. Patients with PD caused 4.8 times higher costs for nursing home placement with euro 18 875 versus euro 3978 per individual and year. The annual costs for institutional care of patients with PD in Norway were euro 132 million.
CONCLUSION: Patients with PD have a substantially higher risk for living in nursing homes than the general population. This causes high costs to society. Therapeutic interventions to prevent or delay nursing home admissions are therefore important.

Entities:  

Mesh:

Year:  2009        PMID: 19146640     DOI: 10.1111/j.1468-1331.2008.02380.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  18 in total

1.  Health state values during the first year of drug treatment in early-stage Parkinson's disease: a prospective, population-based, cohort study.

Authors:  Corinna Vossius; Odd Bjarte Nilsen; Jan Petter Larsen
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

2.  Interdisciplinary palliative care for people with advanced Parkinson's disease: a view from the home.

Authors:  Jori E Fleisher; Ellen C Klostermann; Serena P Hess; Jeanette Lee; Erica Myrick; Joshua Chodosh
Journal:  Ann Palliat Med       Date:  2019-10-14

3.  The health-related, social, and economic consequences of parkinsonism: a controlled national study.

Authors:  Poul Jennum; Marielle Zoetmulder; Lise Korbo; Jakob Kjellberg
Journal:  J Neurol       Date:  2011-03-11       Impact factor: 4.849

4.  Health-related quality of life in Parkinson disease: correlation between Health Utilities Index III and Unified Parkinson's Disease Rating Scale (UPDRS) in U.S. male veterans.

Authors:  Galit Kleiner-Fisman; Matthew B Stern; David N Fisman
Journal:  Health Qual Life Outcomes       Date:  2010-08-30       Impact factor: 3.186

5.  Co-occurring chronic conditions and healthcare expenditures associated with Parkinson's disease: a propensity score matched analysis.

Authors:  Sandipan Bhattacharjee; Usha Sambamoorthi
Journal:  Parkinsonism Relat Disord       Date:  2013-05-13       Impact factor: 4.891

6.  Housing and Health: Very Old People with Self-Reported Parkinson's Disease versus Controls.

Authors:  Maria H Nilsson; Maria Haak; Susanne Iwarsson
Journal:  Parkinsons Dis       Date:  2013-03-26

7.  Home and health in people ageing with Parkinson's disease: study protocol for a prospective longitudinal cohort survey study.

Authors:  Maria H Nilsson; Susanne Iwarsson
Journal:  BMC Neurol       Date:  2013-10-09       Impact factor: 2.474

8.  Temporal Characteristics of High-Frequency Lower-Limb Oscillation during Freezing of Gait in Parkinson's Disease.

Authors:  Don A Yungher; Tiffany R Morris; Valentina Dilda; James M Shine; Sharon L Naismith; Simon J G Lewis; Steven T Moore
Journal:  Parkinsons Dis       Date:  2014-07-02

9.  Deep brain stimulation in Parkinson's disease.

Authors:  Raja Mehanna; Eugene C Lai
Journal:  Transl Neurodegener       Date:  2013-11-18       Impact factor: 8.014

10.  Timing of deep brain stimulation in Parkinson disease: a need for reappraisal?

Authors:  Ruth-Mary deSouza; Elena Moro; Anthony E Lang; Anthony H V Schapira
Journal:  Ann Neurol       Date:  2013-05       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.